Oncology trial systems debut at SCOPE 2026 as AI adoption accelerates
Massive Bio and ConcertAI revealed the AI oncology trial systems at SCOPE 2026.
Artificial Intelligence
Biorce secures $52.5m in Series A to expand AI clinical trial tech
Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
AI-automated IVF procedures represent a new era in fertility treatment
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal
Mastering compliance and copyright in healthcare and MedComms
MWC Barcelona 2025: Maximizing 5G network value in the age of AI
